Table 2 Adjunctive vitamin D therapy in various diseases, adherence to standard guideline
Diagnosed Diseases | Classification (Vitamin D Deficiency) | Total N (%) | Guideline Adherence (Vitamin D Testing) | Adherence to Dose (According to Disease) | ||
|---|---|---|---|---|---|---|
Yes N (%) | No N (%) | Yes N (%) | No N (%) | |||
Respiratory tract infections | Low risk | 143 (35.8) | 101 (70.6) | 42 (29.4) | 66 (49.3) | 77 (57.5) |
Seizure | High risk | 132 (33.0) | 5 (3.8) | 127 (96.2) | 14 (10.6) | 118 (89.4) |
General weakness | Low risk | 112 (28.0) | 96 (85.7) | 16 (14.3) | 74 (66.07) | 38 (33.9) |
Bone deformities | High risk | 60 (15.0) | 8 (13.3) | 52 (86.7) | 19 (31.7) | 41 (68.3) |
Diarrhea, vomiting, abdominal cramp | Low risk | 28 (7.0) | 24 (85.7) | 4 (14.3) | 18 (64.3) | 10 (35.7) |
Steroid resistant nephrotic syndrome | High risk | 25 (6.3) | 0 (0.0) | 25 (100) | 6 (24.0) | 19 (76.0) |
Urinary tract infection | Low risk | 15 (3.8) | 12 (80.0) | 3 (20.0) | 13 (86.7) | 2 (13.3) |
Cerebral palsy | High risk | 17 (4.3) | 1 (5.9) | 16 (94.1) | 8 (47.05) | 9 (52.9) |
Meningitis | High risk | 7 (1.8) | 1 (14.3) | 6 (85.7) | 0 (0.0) | 7 (100) |